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Abstract
 
In this study, we identify and characterize a novel transmembrane adaptor protein, designated
Lck-interacting membrane protein (LIME), as a binding partner of the Lck Src homology
(SH)2 domain. LIME possesses a short extracellular domain, a transmembrane domain, and a
cytoplasmic tail containing five tyrosine-based motifs. The protein is primarily expressed in
hematopoietic cells and lung. Interestingly, LIME expression is up-regulated by TCR stimulation
and sustained up to 24 h, suggesting that LIME acts throughout the early to late stages of T
cell activation. LIME is localized to membrane rafts and distributed within the T cell–APC
contact site. Upon TCR stimulation of Jurkat T cells, LIME associates with Lck as a tyrosine-
phosphorylated protein. Experiments using Jurkat T cells expressing CD8–LIME chimera reveal
that the protein associates with phosphatidylinositol 3-kinase, Grb2, Gads, and SHP2, and activates
ERK1/2 and JNK but not p38. Moreover, overexpression of LIME in Jurkat T cells induces
transcriptional activation of the IL-2 promoter. Our data collectively show that LIME is a raft-
associated transmembrane adaptor protein linking TCR stimuli to downstream signaling pathways
via associations with Lck.
Key words: T cell receptor • signal transduction • lipid rafts • immunological synapse • 
T cell activation
 
Introduction
 
Engagement of the TCR triggers a signaling cascade involving
protein tyrosine kinases (PTKs) (1). Membrane-proximal
TCR signaling comprises redistribution and activation of the
Src kinases, Lck and Fyn, phosphorylation of immunoreceptor
tyrosine-based activation motifs (ITAM) within the CD3
complex, and subsequent recruitment of the tandem SH2
domain–containing tyrosine kinase, ZAP-70, to phosphor-
ylated CD3-
 
 
 
 ITAM. Activated ZAP-70 phosphorylates
specific downstream substrates (2).
Recent studies on TCR-mediated signaling events have
focused on the roles of glycolipid-enriched microdomains
or detergent-insoluble rafts, which are characterized by
enrichment with sphingolipids, cholesterol, and signaling
proteins. The functional importance of membrane com-
partmentation in immune receptor signaling is confirmed
by the report that disruption of rafts due to the depletion of
membrane cholesterol results in attenuation of immune
receptor–mediated calcium mobilization (3). A variety of
signaling molecules are concentrated in rafts, including the
Src family tyrosine kinase Lck. Upon TCR stimulation,
ZAP-70 translocates from the cytoplasm to rafts and phos-
phorylates a transmembrane adaptor protein, linker for
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Abbreviations used in this paper:
 
 Cbp, Csk-binding protein; GFP, green
 
fluorescent protein;
 
 
 
GST, glutathione 
 
S
 
-transferase;
 
 
 
ITAM, immunoreceptor
tyrosine-based activation motif; LAB, linker for activation of B cells;
LAT, linker for activation of T cells; LIME, Lck-interacting membrane
protein; NTAL, non–T cell activation linker; PAG, phosphoprotein asso-
ciated with glycosphingolipid-enriched microdomains; PI3K, phosphati-
dylinositol 3-kinase; PLC, phospholipase C; PTK, protein tyrosine kinases;
pY, phosphotyrosine; SH, Src homology; SIT, SHP2-interacting trans-
membrane adaptor protein; TRIM, TCR-interacting molecule.T
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activation of T cells (LAT) (4). Phosphorylation of LAT
provides a platform for the accumulation of critical sig-
naling molecules, such as Grb2, Gads, phospholipase C
(PLC)-
 
 
 
, and phosphatidylinositol 3-kinase (PI3K) (5, 6,
7). Other members of the transmembrane adaptor protein
group, including TCR-interacting molecule (TRIM) (8),
SHP2-interacting transmembrane adaptor protein (SIT)
(9), and phosphoprotein associated with glycosphingolipid-
enriched microdomains (PAG)/Csk-binding protein (Cbp)
(10, 11) additionally appear to play roles in T cells, al-
though their exact functions remain to be established.
Non–T cell activation linker (NTAL) (12) and linker for
activation of B cells (LAB) (13) were reported recently as
novel transmembrane adaptor proteins expressed in B cells
but not T cells. These findings suggest that in immune re-
ceptor–mediated proximal signaling regulation at the level
of transmembrane adaptors determines the outcome of
downstream signaling events.
The various functions of Lck in T cells are implemented
via both the catalytic activity of the kinase domain and
protein–protein interactions through the regulatory SH2
and SH3 domains (14). In the resting state, the SH2 do-
main of Lck binds a COOH-terminal phosphotyrosine
(pY505), resulting in a catalytically inactive conformation.
Upon T cell activation, pY505 is dephosphorylated and
subsequently the SH2 domain becomes free
 
.
 
 The free SH2
domain is capable of interacting with tyrosine-based motifs
on other signaling molecules, including Lad/RIBP (15,
16). The importance of the SH2 domain in T cell activa-
tion is further supported by the finding that a kinase-inac-
tive Lck mutant is still able to activate signaling events,
leading to IL-2 gene expression. In addition, deletion of
SH2 results in abrogation of the transforming activity of
Lck, confirming the importance of this domain in Lck
function (17).
Accumulating studies report the possibility that specific
subsets of signaling molecules are phosphorylated by indi-
vidual PTK proteins involved in TCR signaling, namely
Lck, Fyn, and ZAP-70. Downstream substrates of ZAP-70,
such as SLP-76 and LAT, contain several phosphotyrosine
sites and protein–protein interaction domains involved in
the recruitment of other signaling molecules (18). Sev-
eral reports suggest that Fyn-binding protein (FYB) and
SKAP55 are specifically involved in Fyn signaling cascades
in T cells. FYB associates with Fyn and serves as a bind-
ing  partner for two Fyn-binding proteins, SKAP55 and
SKAP55R (SKAP55-related protein), which are substrates
for Fyn kinase in T cells (19, 20). However, the specific
contribution of each PTK and its substrates to the down-
stream TCR signaling pathway remain to be determined.
Here, we describe the cDNA cloning and characteriza-
tion of a 30-kD phosphoprotein designated Lck-interacting
membrane protein (LIME) that interacts with the SH2 do-
main of Lck. LIME is a novel raft-associated transmembrane
adaptor protein with five phosphotyrosine sites in the cyto-
solic domain, which is preferentially expressed in hemato-
poietic cells. Expression of this protein is up-regulated by
TCR stimulation. We demonstrate that LIME is a substrate
 
of Lck and a binding partner of the SH2 domain, both in
vitro and in vivo. Importantly, LIME associates with signal-
ing molecules such as PI3K, SHP2, Gads, and Grb2 and ac-
tivates ERK and JNK and the IL-2 promoter. Based on
these results, we propose that LIME is an important compo-
nent of membrane-proximal TCR-mediated signaling.
 
Materials and Methods
 
Cloning of LIME cDNA.
 
All bait plasmids employed for the
yeast two-hybrid system are described in earlier reports (15, 21,
22). LckSH2K (F505) encoding the SH2 and kinase domains
(F505, the constitutively active form) was used as bait for yeast
two-hybrid screening of a murine T cell lymphoma cDNA li-
brary (CLONTECH Laboratories, Inc.). Plasmids were trans-
formed using the lithium acetate method (23). Isolation of posi-
tive clones and subsequent analyses were performed as described
previously (15). Subsequently, to obtain cDNA encoding the
whole open reading frame, a mouse lung cDNA library in 
 
 
 
-gt10
(CLONTECH Laboratories, Inc.) was screened using a 750-bp
fragment of LIME cDNA isolated by yeast two-hybrid screening.
After screening of 4 
 
 
 
 10
 
6
 
 plaques, eight positive clones were se-
lected, and the nucleotide sequences were determined.
 
Plasmids.
 
The expression plasmid encoding LIME, pLIME–
FLAG, was constructed by PCR and subsequent insertion of the
corresponding fragment into pcDNA3.1 (Invitrogen). The 3
 
 
 
primer contained sequence encoding FLAG tag. The primers also
had BamHI (5
 
 
 
 primer and 3
 
 
 
 primer) site extension to facilitate
the subcloning. The PCR product was digested with BamHI and
inserted into corresponding sites in pcDNA3.1(
 
 
 
) (CLONTECH
Laboratories, Inc.). The expression plasmid encoding the domi-
nant negative form of LIME (lacking aa 1–82 including transmem-
brane domain), pFLAG–LIME
 
 
 
N, was also constructed in the
same way. For expression vector encoding LIME–green fluores-
cent protein (GFP), the open reading frame was inserted into
pEGFP-N1 (CLONTECH Laboratories, Inc.). The point mutants
of LIME were generated by substituting individual tyrosine for
phenylalanine using a Quick mutagenesis kit (Stratagene). Expres-
sion plasmid encoding CD8–LIME chimera was constructed fol-
lowing the method described previously (24). Fragments corre-
sponding to human CD8 
 
 
 
 chain (aa 1–188) and LIME cytosolic
region (aa 28–269) were generated by PCR. Primers encoding the
3
 
 
 
 sequences of the CD8 fragment and the 5
 
 
 
 sequences of the
FLAG-tagged LIME fragment were designed to overlap, such that
annealing of the two products yielded a hybrid template. From
this template, the chimera was amplified using external primers
containing XbaI sites. The CD8–LIME chimera was inserted into
pcDNA3.1(
 
 
 
). pcDNA1–Lck (WT), pcDNA1–Lck (F505),
pcDNA1–Lck (A273), and glutathione 
 
S
 
-transferase (GST)–Lck
SH2 constructs were described previously (15). The reporter plas-
mid pGL3/IL-2–luc contains the luciferase reporter gene down-
stream from the IL-2 promoter region including 548 bp 5
 
 
 
 of the
transcription start site and was described previously (15).
 
Northern Blot Analysis.
 
Mouse and human multiple tissue
Northern blots (CLONTECH Laboratories, Inc.) were probed
with a [
 
32
 
P]dCTP-labeled PCR product encompassing the full
open reading frame of LIME. Hybridization was performed at
42
 
 
 
C overnight in buffer containing 50% deionized formamide,
0.5% SDS, 5
 
 
 
 SSC, 5
 
 
 
 Denhardt’s solution, and 0.1 
 
 
 
g/ml
salmon sperm single-stranded DNA.
 
Isolation of Murine Tissue and Primary T Cells.
 
Thymocytes,
splenocytes, and lymphocytes were isolated from Balb/c mice.T
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Resting CD4
 
 
 
 and CD8
 
 
 
 lymphoid T cells were isolated by
positive selection using MACS.
 
Cells and Transfection.
 
Cell lines were obtained from Ameri-
can Type Culture Collection. Jurkat T (E6.1) and Raji B cell
lines were maintained in RPMI1640 medium supplemented with
10% FBS. 293T cells were grown in DME containing 10% FBS,
plated at a density of 2 
 
 
 
 10
 
6
 
 cells per 100-mm dish, and trans-
fected with 15 
 
 
 
g DNA using the calcium phosphate method
(25). 48 h after transfection, cells were harvested and used for im-
munoprecipitation and Western blot analyses. Jurkat T cells were
transfected by electroporation (BTX-co.). Cells (1.5 
 
 
 
 10
 
7
 
) were
combined with 20 
 
 
 
g DNA in an electroporation cuvette, mixed
gently, pulsed once at 240 V for 25 ms, transferred into 10 ml
complete medium, and incubated overnight at 37
 
 
 
C for further
processing. Jurkat T cells stably expressing the CD8–LIME chi-
mera were established by selection in the presence of 1 mg/ml
G418. Stable cells were activated with 5 
 
 
 
g/ml anti-CD8 anti-
body in a total volume of 1 ml.
 
T Cell Activation.
 
Primary T cells were stimulated by cross-
linking with the combination of anti-CD3 and anti-CD28 anti-
bodies to provide both of TCR and costimulatory signals. Jurkat
T cells were stimulated by cross-linking with anti-CD3 antibody.
 
Antibodies.
 
Polyclonal rabbit anti-Lck serum was generated by
immunizing rabbits with GST-conjugated Lck (aa 66–224). Poly-
clonal anti-LIME antisera were generated against either GST fusion
proteins or synthetic peptides. The first method involved produc-
tion of polyclonal rabbit and mouse anti-LIME sera by immunizing
with GST-fused LIME (aa 159–269). The second method involved
immunization of rabbits with KLH-conjugated synthetic peptides.
Out of the six different peptides tested, only one (GPLEN-
VYESIKEMGL) (aa 255–269) effectively generated antiserum that
was capable of detecting LIME on a Western blot. The other anti-
bodies used in this study were obtained from commercial sources,
including monoclonal anti-Lck, anti-Gad, and antiphosphotyrosine
(4G10) (Upstate Biotechnology), anti-LAT, anti–ZAP-70, anti-
PI3K P85, anti-Grb2, and anti-SHP2 (Santa Cruz Biotechnology,
Inc.), anti-CD8, anti–mouse IgG, TRITC–anti–mouse IgG, anti-
CD3, and anti-CD28 (BD Biosciences), FITC-CTx B subunit and
antitalin (Sigma-Aldrich), anti–phospho-ERK1/2, anti–phospho-
JNK, anti–phospho-p38, anti-ERK, and anti-JNK (Cell Signaling),
and anti–Flag M2 (Eastman Kodak Co.) antibodies.
 
Immunoprecipitation and Western Blot Analysis.
 
For immuno-
precipitation, cells were lysed in TNE buffer (50 mM Tris, pH
8.0, 150 mM NaCl, 2 mM EDTA, 1 mM Na
 
3
 
VO
 
4
 
, 5 mM NaF,
25 
 
 
 
g/ml aprotinin, 1 mM PMSF, 25 
 
 
 
g/ml leupeptin, and 1
mg/ml BSA) containing 1% Brij 35 or 1% Digitonin. After incu-
bation for 1 h on ice, insoluble material was removed by centrifu-
gation at 12,000 rpm for 20 min at 4
 
 
 
C. Subsequently, supernatant
samples were precleared for 1 h with normal rabbit serum coupled
to protein A agarose or mouse IgG coupled to agarose (Sigma-
Aldrich) and subjected to immunoprecipitation with the appropri-
ate antibodies and protein A agarose. Western blot analysis was per-
formed using the ECL detection system. (Amersham Biosciences).
 
Purification of the Raft Fraction.
 
CD3-stimulated Jurkat cells
(5 
 
 
 
 10
 
7
 
) were lysed in 1 ml TNE buffer (25 mM Tris, 150 mM
NaCl, 5 mM EDTA) containing 1% Triton. Lysates were ho-
mogenized with 10 strokes of a dounce homogenizer, mixed
with 1 ml of 80% sucrose in TNE buffer, and transferred to a
centrifuge tube. Samples were overlaid with 2 ml of 30% sucrose
and 1 ml of 5% sucrose in TNE. After centrifugation for 16 h at
40,000 rpm in a Beckman Coulter SW41Ti rotor, 10 0.4-ml
fractions were collected from the top of the gradient. Each frac-
tion was precipitated with TCA and washed with 70% EtOH.
 
Immunofluorescense Staining and Confocal Laser Scan Microscopy.
 
Jurkat T cells were transfected by electroporation (BTX co.). Af-
ter incubation for 20 h and washing with PBS, cells were fixed by
immersion in 3.7% formaldehyde (Sigma-Aldrich) at room tem-
perature for 15 min and subsequently in prechilled MeOH. Fixed
cells were transferred to chamber slides and immediately air dried.
Cells were incubated with anti-FLAG antibody (1:100 dilution)
in 3% BSA for 30 min at 30
 
 
 
C. Subsequently, slides were exposed
to TRITC-conjugated mouse secondary antibody and incubated
for 30 min. After mounting, photographs were taken using a
LSM510 Confocal Microscope (Carl Zeiss MicroImaging, Inc.).
As a control, FITC–cholera toxin B subunits were added after
fixation for GM1 staining.
 
T Cell–APC Conjugates Were Formed Using Raji B Cells as
APC.
 
Jurkat T cells were transfected with expression plasmids
encoding LIME–GFP or empty vector. Prior to conjugation,
Raji B cells were incubated in RPMI1640 with 5 
 
 
 
g/ml SEE
(Toxin Technology) at 37
 
 
 
C for 1 h. Jurkat T cells and Raji B
cells were mixed at a 1:1 ratio and density of 10
 
6
 
 cells/ml, imme-
diately transferred to poly-
 
l
 
-lysine–coated slides, and incubated at
37
 
 
 
C for 15 min. Slides were fixed in 3.7% formaldehyde for 20
min at room temperature and processed as described above.
 
Metabolic Labeling of 293T Cells.
 
293T cells were transiently
transfected with LIME expression plasmids in 6-well plates. 24 h
after transfection, cells were labeled with 0.5 mCi 
 
3
 
H-palmitate in
1 ml DMEM containing 5% FCS and 5 mM sodium pyruvate for
4 h. Cell lysates were fractionated on SDS-PAGE gel, which was
fixed, treated with Enlightening (Dupont) for 30 min, dried, and
exposed to x-ray film for 4 wk.
 
In Vitro Binding.
 
FLAG–LIME was translated in vitro (Pro-
mega), phosphorylated using 40 units of purified Lck protein
(Upstate Biotechnology Inc.) in kinase assay buffer (50 mM, Tris,
pH 7.5, 1 mM DTT, 10 mM MnCl
 
2
 
, 50 mM NaCl, 0.1 mM
ATP), and incubated with purified GST or GST–Lck SH2 pro-
teins coupled to glutathione-sepharose beads. After washing,
eluted proteins were separated by SDS-PAGE and subjected to
Western analysis with anti-FLAG antibody.
 
Luciferase Assay.
 
Jurkat T cells (10
 
6
 
) were cotransfected with
appropriate combinations of IL-2–luc reporter construct and ex-
pression plasmids. After incubation for 24 h, cells were activated
by further incubation for 14 h on a 35-mm dish coated with 5
 
 
 
g/ml anti-CD3 antibody (UCHT1) and harvested. Luciferase
activity was determined three times in duplicate for each experi-
ment with a Berthold luminometer LB953. To control for the
transfection efficiency, pCMV–
 
 
 
-gal plasmids were cotransfected
as test plasmids and the luciferase activity was normalized by
 
 
 
-galactosidase activity (Promega).
 
Results
 
Identification of LIME as a Protein Binding to the SH2 Do-
main of Lck.
 
To isolate molecules that associate with the
SH2 domain of Lck in a phosphorylation-dependent man-
ner, a previously established tyrosine phosphorylation–
dependent yeast two-hybrid screening system was used (15,
22). Using this system, we employed part of Lck encom-
passing the SH2 and kinase domains (SH2K) as bait. After
screening 2 
 
 
 
 10
 
6
 
 independent clones of a murine T cell
lymphoma cDNA library, 
 
 
 
70 positive clones were iso-
lated. Here, we characterize a protein detected four times
out of the 70 positive clones, designated LIME.T
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To further assess the binding specificity of LIME to Lck,
we employed various control plasmids as described in Fig.
1 A. Although LIME interacted with Lck–SH2K (F505),
the protein did not bind either SH2 or kinase domain inde-
pendently, implying that association of LIME with Lck re-
quires both SH2 and kinase activity. Moreover, LIME did
not associate with either the SH2 mutant (SH2K [K154/
F505]) that is incapable of binding the phosphotyrosine-
based motif or a catalytically inactive mutant SH2K (A273/
F505). These results collectively suggest that LIME specifi-
cally binds the Lck SH2 domain in a tyrosine phosphoryla-
tion–dependent manner.
 
Structural Features of LIME. 
 
The full-length open read-
ing frame of LIME was subsequently obtained by screening a
mouse lung cDNA library. The characterization of positive
clones disclosed an open reading frame encoding 269 aa res-
idues with a predicted molecular mass of 30 kD (Fig. 1 B).
The amino acid sequence of LIME is characteristic of a
transmembrane adaptor protein. The open reading frame
of murine LIME codes for a leaderless transmembrane
protein with a short 9-aa extracellular region, an 18-aa hy-
drophobic membrane-spanning portion, and a 242-aa cy-
toplasmic tail. These structural features of LIME are similar
to those of the recently identified immune cell-specific
transmembrane adaptor proteins, LAT (4), TRIM (8), SIT
(9), and Cbp/PAG (10, 11). LIME additionally contains a
CXXC motif proximal to the transmembrane domain. In
LAT, this sequence serves as a site for palmitoylation,
which is essential for raft targeting of LAT (2). LIME con-
tains five potential tyrosine phosphorylation sites in the
cytosolic domain, which may play roles in forming signal-
ing complexes with SH2 domain–containing molecules.
These structural features indicate that LIME functions as a
docking protein capable of recruiting various signaling
molecules. Using the murine LIME sequence, we identi-
fied the human homologue from the NCBI database.
Conceptual translation of human LIME cDNA showed
295 aa (Fig. 1 B). Moreover, alignment of the murine and
human sequences showed extensive identity between the
two proteins. In particular, the transmembrane domain,
CXXC motif, and five potential phosphotyrosine motifs
are conserved (Fig. 1 B).
Figure 1. cDNA cloning and the deduced amino
acid sequence of LIME. (A) Binding specificity of
LIME to Lck in a yeast two-hybrid system. Indicated
regions of Lck were employed as bait and tested for
binding to LIME. A part of LIME encompassing aa
D52–270 was employed as prey. The binding affinity
was scored as     (deep blue),    (intermediate
blue),   (pale blue), and   (white) upon X-Gal
(5-bromo-4-chloro-3-indoyl   -d-galactoside) stain-
ing. (B, top) The deduced amino acid sequences of
mouse and human LIME and structural characteristics
of the proteins. The transmembrane domain (TM)
and CXXC motif are marked by bold lines. Putative
tyrosine-based motifs are marked by thin lines on
top of the sequence. Sequence data available from
GenBank/EMBL/DDBJ under accession no.
AF115339. (B, bottom) Schematic diagram of the
predicted structure of murine LIME.T
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Tissue Distribution of LIME.
 
On a Northern blot of
mouse tissues, the LIME transcript was detected as a 1.5-kb
band mainly restricted to the spleen and lung (Fig. 2 A).
Among the human tissues, LIME mRNAs were observed
in spleen and peripheral blood lymphocytes, although a
much lower signal was detected in other tissues tested (Fig.
2 B). Therefore, it is likely that LIME is expressed predom-
inantly in both hematopoietic cells and lung. LIME expres-
sion was additionally analyzed by Western blotting with
anti-LIME antiserum. In vitro–translated LIME migrated as
an 
 
 
 
30-kD protein, concurrent with the size estimated
from the deduced amino acid sequence (unpublished data).
Western blot analysis of lymphoid tissues revealed that
LIME was expressed at a comparable level in spleen and
CD4
 
 
 
 and CD8
 
 
 
 T cells from LN but not in thymus, indi-
cating that among T cell subsets LIME expression is re-
stricted to peripheral T cells (Fig. 2 C). Various hematopoi-
etic cell lines were additionally tested for LIME expression.
Protein was detected in most of the hematopoietic cell lines
tested, including K562 (erythroleukemia), Raw264.7 (mac-
rophages), WEHI231, Raji (B cells), EL4 (thymus), and
Jurkat (T cell) cell lines (Fig. 2 D). The results indicate that
LIME is predominantly expressed in hematopoietic cells
such as T, B, and macrophage.
Having determined that LIME is expressed in T cells, we
were interested in establishing whether expression is regu-
lated upon TCR stimulation. Resting T cells were isolated
from mouse LNs, stimulated by CD3 and CD28 cross-
linking and analyzed for the levels of LIME protein and
mRNA. Interestingly, LIME protein was up-regulated
upon TCR stimulation, reaching the maximum level
within 1 h and was sustained up to 24 h (Fig. 2 E). In addi-
tion, LIME mRNA was also up-regulated but with a
slower kinetics. The level of LIME mRNA reached a peak
level at 6 h and was sustained up to 24 h (Fig. 2 F). The
observed difference in kinetics of LIME expression suggests
that LIME expression is regulated at both protein and
mRNA levels. The inducible expression pattern also sug-
gests that the protein operates throughout the early to late
stages of T cell activation.
 
LIME Localizes To Membrane Rafts and Immunological Syn-
apses.
 
To ascertain the function of LIME, we determined
the localization pattern of the protein. Jurkat T cells were
either left unstimulated or stimulated with anti-CD3 anti-
body and stained with a combination of rabbit anti-LIME
antiserum and Texas red–conjugated anti–rabbit IgG. As a
control for membrane raft fraction, the FITC–cholera
toxin B subunit was employed for detecting GM1, an es-
tablished marker of raft. Before TCR stimulation, LIME
was evenly distributed throughout the plasma membrane.
The protein translocated to the capping site after TCR
stimulation (Fig. 3 A). Regardless of the absence or pres-
ence of TCR stimulation, the staining pattern of LIME
overlapped exactly with that of the cholera toxin B sub-
unit, suggesting that the protein specifically localizes to
membrane raft.
To biochemically confirm raft localization of LIME, we
fractionated Jurkat T cell lysates by sucrose gradient ultra-
Figure 2. Expression profiles of LIME.
(A and B) Northern blot analyses on mouse
(A) and human (B) tissues. Multiple Tissue
Northern blots were performed using LIME
cDNA as a probe. The positions of the
LIME transcript are indicated by arrow-
heads. A  -actin cDNA probe was used as
control (bottom). (C) Expression of LIME
in murine lymphoid tissues. Western blot
analyses were performed on cell lysates isolated
from indicated tissues (2   106 cells/lane)
using polyclonal mouse anti-LIME anti-
body. (D) Western blot analysis of LIME
expression in various cell lines. Whole cell
lysates (2   106 cells/lane) from indicated
cell lines were immunoblotted with mouse
anti-LIME antiserum. 293T, human embry-
onic kidney; K562, human erythroleukemic
cells; Raw 264.7, macrophage; WEHI 231,
murine B cell; Raji, human B cell; EL-4,
murine thymoma; Jurkat, human T cell
leukemia. The same membrane was immuno-
blotted with anti– -actin antibody. (E) West-
ern blot analysis of LIME expression upon T
cell activation. Resting lymphoid T cells
were stimulated in vitro with anti-CD3 
and anti-CD28 mAb for the indicated
times. LIME expression was determined by
Western blotting. (F) Northern blot analysis
of LIME expression upon TCR activation.
Resting lymphoid T cells were stimulated
and processed as described in E. GAPDH
cDNA probe was used as control (bottom).T
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centrifugation and analyzed fractions by Western blotting
with anti-LIME antiserum. The protein was mainly de-
tected in the raft fraction, even in the absence of TCR
stimulation (Fig. 3 B). A control experiment with LAT as a
marker for raft fractions and ZAP-70 for nonraft fractions
confirmed that fractionation was performed properly. We
conclude that LIME is a constitutive component of raft.
Next, the presence of C
 
28
 
XXC
 
31
 
 motif in the membrane-
proximal region of LIME led us to test whether LIME is
palmitoylated on this motif and if the palmitoylation is re-
sponsible for localization of LIME in membrane raft. Cys 28
and Cys 31 of LIME were mutated to serine (C
 
→
 
S LIME).
Subsequently, WT or C
 
→
 
S LIME was transiently expressed
in 293T cells in the presence of 
 
3
 
H-palmitate and subjected
to immunoprecipitation. The immunoprecipitates were ana-
lyzed by immunoblotting (Fig. 3 C, top) or autoradiography
(Fig. 3 C, bottom). WT LIME but not C
 
→
 
S LIME was la-
beled indicating that LIME is palmitoylated on membrane-
proximal cysteines. Subsequently, the localization of WT
and C
 
→S LIME was studied by sucrose gradient fraction-
ation. As shown in Fig. 3 D, C→S LIME localized in non-
raft fraction, indicating that the palmitoylation of LIME is
required for its localization to membrane raft.
Having determined the localization of LIME to mem-
brane raft, we were interested in trafficking of the protein
upon T cell–APC conjugation. Jurkat T cells were trans-
fected with constructs expressing GFP–LIME and allowed
to conjugate with SEE-pulsed Raji B cells as APC. Using
confocal microscopy, we observed that LIME localized to
the T cell–APC contact site with a pattern overlapping that
of talin, a synapse marker (Fig. 3 E). In view of the results
in the preceeding paragraphs, we conclude that LIME is a
constitutive component of membrane raft that is recruited
to the immunological synapse upon conjugation of T cells
with APC. The results additionally suggest that the adaptor
protein is involved in T cell activation signaling.
LIME Associates with Lck in T Cells. We next investi-
gated the association between LIME and Lck in Jurkat T
cells upon TCR stimulation. Jurkat T cell lysates, either left
unstimulated or stimulated by CD3 cross-linking, were sub-
jected to immunoprecipitation with anti-Lck mAb. Normal
mouse IgG was used as a negative control for immunopre-
cipitation. Analysis of immunoprecipitates by Western blot-
ting with anti-LIME antiserum revealed LIME only in anti-
Lck immunoprecipitates of CD3-stimulated cells (Fig. 4 A,
top). Subsequent reprobing with antiphosphotyrosine anti-
body showed that the protein coprecipitating with Lck was
phosphorylated (Fig. 4 A, middle). Our results confirm that
LIME associates with Lck in the phosphorylated form, and
interactions are induced by TCR stimulation.
Figure 3. LIME localizes to
membrane raft and is distributed
within the immunological synapse
upon contact with APC. (A)
LIME cocaps with GM1. Jurkat
T cells were either left unstimu-
lated ( , top) or stimulated
( , bottom) with anti-CD3
(UCHT1). Subsequently, cells
were stained with FITC-labeled
cholera toxin B subunit (CTx)
or anti-LIME antibody and
Texas red–conjugated anti–rabbit
IgG. (B) LIME localizes to raft.
Jurkat T cells were stimulated
with anti-CD3 for 10 min and
solubilized in 1% Triton X-100.
Lysates were subjected to sucrose
gradient ultracentrifugation, and
fractions (numbered 2–11 from
top to bottom) were analyzed
by immunoblotting with anti-
LIME, anti-LAT, or anti-ZAP70
antibodies. LAT was employed
as an established control marker
of raft fraction. (C) LIME is
palmitoylated. 293T cells were
transfected with the expression
plasmids encoding FALG-tagged
WT LIME or mutant LIME in
which Cys28 and Cys31 were
mutated to serine (C→S LIME)
and metabolically labeled with 3H-palmitate for 4 h. LIME proteins were immunoprecipitated with anti-FLAG antibody, and the immunoprecipitates
were analyzed by immunoblot (top) and autoradiography (bottom). (D) Palmitoylation of membrane-proximal cysteines is required for localization of
LIME to membrane raft. Cell lysates were prepared as described in C and subjected to sucrose gradient centrifugation. The fractions were analyzed by
immunoblotting with anti-FLAG antibody. (E) Localization of LIME to the APC–T cell contact site. Jurkat T cells transfected with expression plasmids
encoding LIME–GFP were mixed at a ratio of 1:1 with SEE-pulsed Raji B cells. Cells were fixed and examined by confocal microscopy. Recruitment
of LIME to T cells was characterized by a bright band at the cell interface.T
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Association of LIME with Lck Requires Tyrosine Phosphory-
lation. To address whether phosphorylation of LIME by
Lck is required for binding, we investigated associations be-
tween LIME and the Lck SH2 domain in vitro (Fig. 4 B).
FLAG-tagged LIME was expressed by in vitro translation
and subjected to phosphorylation in vitro by purified Lck
kinase. The reaction mixture was subsequently incubated
with GST or GST–Lck SH2 fusion proteins coupled to
glutathione-sepharose beads, and bound proteins were
analyzed by Western blotting with anti-FLAG antibody.
LIME was detected in GST–Lck SH2 precipitates only in
the presence of Lck kinase (Fig. 4 B). These results indicate
that LIME functions as a direct binding partner of Lck SH2
and is a substrate of Lck kinase.
To identify the LIME motifs responsible for binding to
Lck, we coexpressed tyrosine mutants of LIME with Lck
F505 in 293T cells by transient transfection and examined
binding abilities. Initially, the five tyrosines in the cytosolic
domain of LIME were individually substituted using site-
directed mutagenesis and examined for binding to Lck. All
of the single tyrosine mutants coimmunoprecipitated with
Lck F505, suggesting that multiple tyrosines are involved in
binding (unpublished data). Accordingly, we generated
double or triple tyrosine mutants and examined binding. As
shown in Fig. 4 C, double LIME mutants (Y242F and
Y261F) failed to bind Lck. We conclude that the specific
amino acids of LIME that bind Lck SH2 are Y242 (YEAI)
and Y261(YESI).
Figure 4. Binding of LIME to Lck. (A) In vivo association between
LIME and Lck in T cells. Jurkat T cells were either left unstimulated or
stimulated for 5 min by CD3 cross-linking. Digitonin lysates (1%) were
subjected to precipitation with anti-Lck mAb or mouse IgG. Precipitates
were analyzed by immunoblotting with anti-LIME and anti-phosphoty-
rosine mAbs. The amount of immunoprecipitated Lck is shown in the
bottom panel. (B) LIME binds the Lck SH2 domain. Purified GST and
GST–Lck SH2 fusion proteins were separated by SDS-PAGE and subjected
to Coomassie staining (top). Subsequently, in vitro–translated FLAG–
LIME was subjected to in vitro phosphorylation by purified Lck kinase
and incubated with GST or GST–Lck SH2–coupled beads. Eluted pro-
teins were separated by SDS-PAGE and immunoblotted with anti-FLAG
antibody (bottom). (C) Mapping of sites in LIME responsible for binding
to Lck. Tyrosine mutants of LIME were coexpressed with Lck in 293T
cells by transient transfection. LIME mutants were immunoprecipitated
with anti-FLAG mAb and analyzed by Western blotting with anti-Lck
polyclonal antiserum (top). To control the amounts of precipitated LIME
derivatives, the same membrane was blotted with anti-FLAG mAb after
stripping (bottom).
Figure 5. LIME mediates activation of ERK and JNK. (A) Structure of
CD8–LIME chimera used in this study. The COOH termini of chimera
were tagged with FLAG. (B) Jurkat T cell lines stably expressing CD8–
LIME were established, and expression levels of chimeric proteins in two
independent clones (clone #1, #2) were determined by Western blotting
using anti-FLAG mAb. The blot was stripped and reincubated with anti-
Grb2 mAb as a control. (C) LIME activates ERK1/2 and JNK but not
p38. Jurkat T cells stably expressing the CD8–LIME chimera were left
unstimulated or stimulated by CD8 cross-linking. Phosphorylation of
MAP kinases was determined by blotting with antibodies specific for
phosphorylated JNK, ERK1/2, and p38. The same blot was stripped and
reprobed with anti-ERK1/2 or JNK.T
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LIME Activates ERK and JNK. To determine the sig-
naling pathways regulated by LIME, we established Jurkat T
cell lines stably expressing chimera of the CD8 extracellular
domain and the cytoplasmic domain of LIME (Fig. 5 A).
Since Jurkat T cells are devoid of CD8 surface expression,
CD8 cross-linking is expected to induce LIME-specific sig-
nals. Initially, chimera expression levels were quantitated by
Western blotting using anti-FLAG mAb (Fig. 5 B, top), and
CD8–LIME chimeric molecules were detected at the ex-
pected mol. wt. of 49 kD. Anti-Grb2 mAb was used as a
control (Fig. 5 B, bottom). One of the most commonly used
criteria to assess early activation events is MAPK phosphory-
lation (26). We assessed whether LIME-specific signals led to
MAPK activation, using a cell line expressing CD8–LIME
chimera (Fig. 5 C). After cross-linking with CD8 antibody,
ERK1/2, JNK, and p38 activation were analyzed by West-
ern blotting with antibodies specific for the phosphorylated
forms. Phosphorylation of ERK1/2 and JNK, but not p38,
was detected (Fig. 5 C). As controls, the same blots were an-
alyzed by Western blot with anti-ERK1/2 and anti-JNK
antibodies. Our results demonstrate that LIME is involved in
the activation of ERK and JNK pathways in T cells.
Association of LIME with Grb2, Gads, PI3K, and SHP2 in
T Cells. Since LIME contains five tyrosines in the cyto-
plasmic tail, we hypothesized that SH2-containing signal-
ing molecules could be recruited by the protein. Using a
Jurkat T cell line stably expressing CD8–LIME chimera,
we analyzed the binding partners of LIME. Immuno-
precipitation of CD8–LIME with anti-FLAG antibody
and subsequent Western blotting with anti-pY antibody
showed that several tyrosine phosphorylated proteins with
approximate mol. wt. of 85, 76, 70, 63, 40 kD coimmuno-
precipitated with LIME (Fig. 6 A). Based on the molecular
weights of phosphoproteins coimmunoprecipitating with
LIME, we analyzed precipitates with a panel of antibodies
specific for SH2 domain–containing signaling molecules.
As shown in Fig. 6 B, the p85 regulatory subunits of PI3K,
SHP2, Gads, and Grb2 were specifically detected in CD8–
LIME immunoprecipitates. The data imply that LIME is
present in signaling complexes containing various SH2 do-
main–containing molecules.
LIME Induces TCR-mediated IL-2 Gene Expression. The
data presented in the previous paragraphs show that LIME
is involved in TCR-mediated signaling. To further assess
the functional roles of the protein, we examined the effects
of overexpression of WT or mutant LIME (LIME N
[lacking aa 1–82]) on IL-2 promoter–driven gene expres-
sion in Jurkat T cells. Since LIME N lacks the transmem-
brane domain but retains potential binding sites for signal-
ing molecules, it presumably acts as a dominant-negative
form by sequestering LIME-associated proteins. The same
approach was successfully employed for another transmem-
brane adaptor protein, LAT (27). Overexpression of LIME
in the absence of CD3 stimulation led to sixfold induction
of IL-2 promoter activity, indicating that the protein is in-
volved in T cell signaling events leading to IL-2 gene ex-
pression (Fig. 7 A). Moreover, the transient overexpression
of LIME N, a dominant-negative form, resulted in re-
duced CD3-stimulated reporter activity by  75% (Fig. 7
A), indicating a requirement of LIME in TCR-mediated
IL-2 gene expression.
To further determine the functional significance of inter-
action between LIME and Lck in T cell activation, we ex-
amined the effects of Lck A273 mutant overexpression on
LIME-mediated IL-2 promoter activation in Jurkat T cells.
Lck A273 lacks kinase activity and was established previ-
ously as a catalytically inactive form of Lck. Overexpression
Figure 6. LIME recruits various SH2 domain–containing signaling
proteins. (A) Jurkat T cells expressing CD8–LIME chimera were analyzed
by immunoprecipitation with anti-FLAG antibody and subsequent Western
blotting with anti-pY 4G10 mAb. Tyrosine-phosphorylated bands detected
only in immunoprecipitates of CD8–LIME chimera–expressing cells are
marked by arrows. (B) The same blot was stripped and reprobed with
anti-PI3K p85 subunit, anti-SHP2, anti-Gads, anti-Grb2, and anti-FLAG
antibodies. HC, IgG heavy chain.
Figure 7. LIME mediates TCR cross-linking–induced
IL-2 promoter activation. (A and B) Jurkat T cells
were cotransfected with 0.75  g each of IL-2–luc
reporter and empty vector or the indicated amounts of
plasmids. Cells were either left unstimulated or stimu-
lated with anti-CD3 antibody and subsequently assayed
for luciferase activity. Results are depicted as fold
stimulation compared with activity in unstimulated
cells transfected with empty vector. Each experiment
was performed three times in duplicates and normal-
ized by  -galactosidase activity from cotransfected
pCMV– -gal.T
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of Lck A273 completely inhibited LIME-mediated IL-2
promoter activity (Fig. 7 B), indicating involvement of Lck
in LIME-mediated signaling leading to IL-2 gene activa-
tion. The results collectively suggest that LIME function is
Lck dependent and the protein plays an essential role in
transmitting TCR-mediated T cell activation signals to IL-2
gene expression via association with Lck.
Discussion
One of the most widely accepted paradigms in TCR sig-
nal transduction is that TCR proximal signaling is initiated
by the activated Src-type kinases, Lck and Fyn, leading to
ITAM phosphorylation on the TCR subunit (2). Phos-
phorylated ITAM promotes recruitment and subsequent
stimulation of ZAP-70 kinase. Adaptor proteins, LAT and
SLP-76, which are established ZAP-70 substrates, recruit
several other proteins involved in downstream signaling
pathways (4). In contrast, although the importance of Lck
in T cell activation is well established, its downstream tar-
gets and effectors remain to be determined. Here, we re-
port the identification and characterization of a novel Lck
substrate, LIME, which may potentially bridge the gap
between Lck-mediated membrane-proximal events and
downstream signaling pathways in T cell activation.
To date, four different transmembrane adaptor proteins,
specifically, LAT (6), TRIM (8), SIT (9), and Cbp/PAG
(10,11) have been reported in T cells. These proteins dis-
play similar structures but different functions. In particu-
lar, during T cell activation the function of LAT is well
defined (5). Although LIME and LAT share common
characteristics in terms of localization to the immunologi-
cal synapse, binding proteins, activation of MAPK, and
IL-2 promoter, several differences are observed between
the two proteins. First, whereas LAT is a substrate of
ZAP-70, LIME is identified as a substrate and a binding
partner of Lck. With regard to this issue, we examined the
possibility of LIME as a substrate for Syk family kinases by
coexpressing LIME and Syk in 293T cells. Our results
show that LIME is not phosphorylated by Syk (unpub-
lished data). Therefore, it appears that LIME is a substrate
of Lck kinase but not ZAP-70. Second, tissue expression
patterns of LIME and LAT are distinct. In addition to T
cells where LAT is expressed, LIME is detected in most of
hematopoietic cells tested. Third, LIME expression is up-
regulated upon TCR stimulation (Fig. 2 E), indicating
that the protein may have a sustained role at a later stage
of T cell activation or in effector T cells. These character-
istics suggest that LIME plays unique roles related to Lck
signaling and a sustained role throughout the later stages
of T cell activation.
Several data in this report show that LIME acts as a sig-
naling molecule in the early stages of T cell activation. Al-
though LIME is specifically up-regulated upon TCR stim-
ulation, a considerable amount of protein is detected in
resting T cells (Fig. 2 C). Furthermore, 5 min after TCR
stimulation LIME associates with Lck and localizes to the
capping site, raft fractions, and immunological synapse (Fig.
3). It is plausible that on localization to synapse LIME pro-
vides a docking site upon which signaling complexes con-
taining Grb2, Gads, PI3K, and SHP2 are assembled. Once
recruited to the LIME-based signaling complex, Grb2 and
p85 subunits of PI3K may activate the Ras-MAPK and
PI3K pathways, respectively, whereas Gads may act as an
adaptor for the recruitment of SLP-76 and PLC-   as
shown previously for LAT (6). In this regard, we addition-
ally tested PLC-  binding to LIME using coimmunopre-
cipitation studies and detected weak binding (unpublished
data), possibly reflecting an indirect mode of recruitment of
PLC-  though Gads and SLP-76.
The finding that LIME expression is up-regulated upon
TCR stimulation and sustained for at least 24 h suggests
that in addition to its role in early T cell activation the pro-
tein may have specific functions at later stages of T cell ac-
tivation or in effector T cells. Although there are many dif-
ferent possibilities for the function of LIME at later stages
of T cell activation, one possible scenario is that LIME acts
in the stabilization of APC-T cell conjugate. Previously, it
has been shown that sustained TCR engagement up to 20
h (28) or at least 2 h (29) in length is required for activation
of naive T cells. Furthermore, it has been shown that
APC–T cell conjugation is dependent on Lck but not
ZAP-70 (30–32), suggesting a unique role of Lck in conju-
gate stabilization. Therefore, as a binding partner of Lck
LIME may be involved in stabilization of the APC–T cell
conjugate. In relation to this possibility, Lck has been
shown to play a role in the intermediate to late stages of T
cell activation (33). The investigators additionally demon-
strated that intracellular pools of Lck associated with recy-
cling endosomes translocating to the immunological syn-
apse, and inhibition of Lck kinase activity within up to 24 h
of conjugation leads to a severe reduction in T cell acti-
vation (33). Therefore, although supporting data are insuf-
ficient at this stage, we hypothesize that LIME acts as a me-
diator of Lck signaling in the stabilization of APC–T cell
conjugates and thereby contributes to the full activation of
T cells. Alternatively, LIME may play an undefined role in
events occurring at later stages of T cell activation.
Structurally, LIME is similar to other transmembrane
adaptor proteins, such as LAT (4), Cbp/PAG (10,11),
NTAL (12), and LAB (13). All of these proteins are charac-
terized by the presence of a short extracellular domain, a
transmembrane domain, and a long cytoplasmic tail con-
taining multiple phosphotyrosine sites. In the membrane-
proximal region of the cytoplasmic side, LIME contains a
CXXC motif, which is also present in LAT, Cbp/PAG,
NTAL, and LAB. In LAT, the motif was shown to serve as
a palmitoylation site essential for targeting to raft (34). The
results in this paper show that LIME is palmitoylated on the
CXXC motif and the palmitoylation is essential for local-
ization to raft (Fig. 3, C and D). In the cytoplasmic do-
main, murine LIME contains two overlapping, proline-rich
SH3-binding motifs (RQLPRAPPAAP), which corre-
spond to the type I SH3 binding motif, RxxPxxP (35, 36).T
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However, this sequence is not conserved in human LIME,
and it remains to be established whether it binds SH3. As
expected from the presence of multiple tyrosines in the cy-
toplasmic domain, LIME associates with SH2-containing
signaling molecules, including PI3K, Gad, Grb2, and SHP2
(Fig. 6 B). In accordance with previous binding specificity
studies between various SH2-containing proteins and
phosphotyrosine sites (37, 38), pY242EAI and pY261ESI mo-
tifs of LIME closely resemble the Lck SH2 domain binding
motif, pYEEI, and are actually mapped as binding sites for
Lck SH2 (Fig. 4 C). Additionally, pY137SNV is a potential
binding site for Grb2 and Gads (defined as pYxN) (39).
Another noteworthy point is the presence of an immu-
noreceptor tyrosine-based inhibition motif (ITIM)3 with a
consensus sequence of (I/L/V)xYxx(L/V) (40). The im-
munoreceptor tyrosine-based inhibition motif in LIME,
VLY207SRV, significantly corresponds to the consensus se-
quence and may serve as a binding site for SHP2.
In addition to its role in T cell activation, LIME may
function as an adaptor in other cell types. Expression analy-
ses revealed LIME protein in most of hematopoietic cells
tested such as T, B, macrophage, and erythroleukemic cell
lines. In this regard, LIME differs from LAT, NTAL, and
LAB; LAT is restricted to T and mast cells, whereas NTAL
and LAB are not expressed in T cells. Thus, it is possible
that LIME acts as a docking protein in response to BCR
stimulation. In addition, the detection of a LIME transcript
in lung tissue suggests that the protein may have a specific
role in lung tissue.
In summary, we have identified a novel transmembrane
adaptor protein, LIME, as a binding partner of Lck upon
TCR stimulation. The protein is expressed in T cells, and
upon TCR stimulation expression is up-regulated, suggest-
ing that LIME functions in the early to late stages of T cell
activation. Further studies with knockout mice are pro-
posed for characterizing the function of LIME in detail.
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